Automated insulin delivery

| Updated on January 16, 2018


The US FDA has approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose levels and provide appropriate basal insulin doses in people aged 14 and above, with type 1 diabetes.

The MiniMed 670G, often referred to as an “artificial pancreas,” is intended to adjust insulin levels with little or no input from the user. It measures glucose levels every five minutes and automatically administers or withholds insulin.

Published on September 30, 2016

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like